Turn this list into pipeline.
Pharmaceuticals Companies in the UK: 5,700+ Active Firms (2026)
Pharmaceutical companies develop, manufacture, license and distribute human medicines in the UK under MHRA oversight.
Commercial buying centres tend to sit in regulatory affairs, quality-assurance, supply-chain, medical and market-access teams rather than a single central procurement function. Buyers include public-sector healthcare bodies, clinical-service providers, wholesalers, export distributors and research-intensive life-sciences groups, with sales often shaped by licence scope, batch release, pharmacovigilance responsibility and cold-chain or controlled-storage needs. Engagements are usually mid-market or enterprise in character: long procurement cycles, qualification of facilities, recurring supply or distribution contracts, and specialist staff on both sides. Smaller firms still appear in the cohort, but the behavioural fit is closer to regulated medicines operations than general healthcare services or consumer wellness.
Read more
The UK cohort contains 5,755 actively trading pharmaceutical companies, making it a sizeable medicines-development, manufacturing and distribution base rather than a narrow research cluster. Turnover depth is more uneven: 329 firms report more than £5M in turnover, while 1,613 have been incorporated since 2022. That mix gives the list an early-commercial tail alongside a smaller set of established licence holders and distributors. Reported employment totals 3,615 people, so the visible headcount footprint is concentrated compared with the company count, consistent with outsourced manufacturing, specialist importers and lean regulatory-holding entities.
MHRA oversight reaches well beyond product approval. Making, assembling or importing human medicines requires a manufacturer’s licence, evidence of good manufacturing practice and regular site inspection; wholesale supply to parties other than the patient requires a wholesale distribution licence and good distribution practice compliance. Medicines also need marketing authorisation, with post-market pharmacovigilance running alongside commercial supply. ABPI represents research-based pharmaceutical companies, while public reimbursement is shaped by health-technology assessment and cost-effectiveness review. Market structure therefore reflects regulation as much as demand: firms may specialise in licence ownership, manufacturing, import, distribution or research support without covering the full chain.
Scale-up scarcity appears to matter more than company formation. The cohort has a long tail of recently formed or tightly scoped businesses, but medicines work tends to reward firms that can carry regulatory responsibility, maintain qualified facilities and manage evidence obligations after launch. Contract manufacturing, specialist distribution and licence-holding models may keep the market fragmented, while market-access pressure pushes smaller developers towards partnerships rather than full-stack commercialisation. Research-led firms also face a longer route to revenue than many software or services businesses, so consolidation is likely to remain selective and activity-led rather than a simple roll-up of small companies.
5,755
Active firms
2026
329
Above £5M
Revenue threshold
1,613
Recent incorporations
Since 2022
Key facts
About 5% of the trading cohort reports turnover above £5M (329 of 5,755 firms) — the rest sits below that revenue band.
28% of the cohort was incorporated since 2022 (1,613 firms), so a sizeable share is in its first few filing cycles.
Human medicines sit under MHRA oversight, with manufacturer’s licences, good manufacturing practice and regular site inspections required for organisations that make, assemble or import them.
Wholesale supply to anyone other than the patient needs a wholesale distribution licence and good distribution practice compliance.
UK businesses performed £9.0 billion of pharmaceutical R&D in 2022, equal to 0.36% of GDP and 18% of all UK business R&D.
Pharmaceutical manufacturing GVA reached £13.7 billion in 2021, the highest value in the 2013–2021 government series.
UK pharmaceutical exports were £25.6 billion in 2023, ranking tenth among comparator countries.
Top UK pharmaceuticals companies
A - Z HEALTHCARE ( UK ) LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsResearches, develops, manufactures and commercialises prescription medicines and vaccines. Focuses on therapeutic areas including oncology, cardiovascular, renal and metabolic diseases, respiratory…
Serves UK healthcare stakeholders including NHS organisations, healthcare professionals, patient groups, government and policy makers, alongside patients in specialist therapy areas such as oncology,…
Financial Health
HealthyHealthy · Hiring · 12% CAGR over 4y
Location
STERLING PHARMACEUTICALS LIMITED
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsResearches, develops, manufactures and tests pharmaceutical products. Operates R&D and manufacturing facilities producing medicines for commercial customers, with products manufactured and quality…
Serves pharmaceutical and healthcare-sector customers worldwide, including organisations that buy EU GMP-compliant medicines and related manufacturing or testing support.
Financial Health
HealthyHealthy · -2% CAGR over 3y
Location
CRESCENT PHARMA LIMITED
Trajectory
3y · 2020–NowFinancial sub-scores
Computed from 3 filingsManufactures and distributes generic pharmaceutical medicines. Produces solid and liquid drug formulations, manages marketing authorisations, and supplies medicines to wholesalers, pharmacies,…
Sells B2B to the UK healthcare supply chain, including the NHS, Department of Health, wholesalers, distributors, pharmacies, hospitals, clinics and retail outlets. Also serves export customers and…
Financial Health
HealthyHealthy · Profitable · -10% CAGR over 2y
Location
Trajectory
3y · 2022–NowFinancial sub-scores
Computed from 3 filingsDevelops, manufactures, markets and distributes generic pharmaceutical medicines. Supplies a range of prescription drugs including analgesics, cardiovascular and antibiotic treatments such as…
Serves NHS contractors, pharmaceutical suppliers and wholesale/distribution buyers in the UK market for generic medicines.
Financial Health
WeakWeak
Location
Seacross Pharmaceuticals Ltd
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops, manufactures and distributes prescription injectable medicines. Conducts pharmaceutical research and development and supplies products and APIs covering therapeutic areas including…
Serves healthcare-sector buyers globally, including hospital pharmacies, clinicians, medicines distributors, and pharmaceutical manufacturing or distribution partners in oncology, urology, CNS and…
Financial Health
HealthyHealthy · 0% CAGR over 2y
Location
TARGET HEALTHCARE LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsManufactures and supplies unlicensed “specials” medicines and distributes generic and branded pharmaceuticals. Provides wholesale supply to pharmacies, hospitals and healthcare providers, including…
Serves B2B healthcare buyers including pharmacies, hospitals, dispensing doctors, pharmaceutical wholesalers and buying groups in the UK and worldwide, with export customers across over 100 countries…
Financial Health
HealthyHealthy · Hiring · 32% CAGR over 4y
Location
NORTHUMBRIA PHARMA LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsResearches, develops, manufactures, and licenses pharmaceutical products, including new chemical entities and generic medicines. Provides services such as pharmacovigilance, regulatory affairs…
Serves pharmaceutical companies, supply partners, healthcare providers and healthcare professionals, with products ultimately targeting patients needing affordable medicines and unmet-need therapies.
Financial Health
StableStable · -67% CAGR over 4y
Location
NOUMED LIFE SCIENCES LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsManufactures, packages and distributes generic pharmaceutical products. Operates facilities for dosage‑form production, quality control testing, regulatory compliance and warehousing, and markets…
Serves UK healthcare and pharmaceutical-sector customers, including organisations sourcing generic medicines and related life sciences products.
Financial Health
WeakWeak · -63% CAGR over 4y
Location
TARGET HEALTHCARE INTERNATIONAL LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsSupplies and manufactures generic, branded and unlicensed medicines to pharmacies, hospitals, dispensing doctors and wholesalers. Provides custom “specials” medicines, parallel imports, medical…
Serves pharmacies, hospitals, dispensing doctors, pharmaceutical wholesalers and buying groups in the UK and internationally, including healthcare providers and distributors needing licensed,…
Financial Health
StableStable · 1% CAGR over 4y
Location
Trajectory
2y · 2024–NowFinancial sub-scores
Computed from 2 filingsResearches, develops, manufactures and sells pharmaceutical products and medical devices. Produces healthcare treatments and related products intended for use by healthcare professionals and patients.
Serves a mix of healthcare professionals and patients, with pharmaceutical and medical-device related audiences in the UK and internationally.
Financial Health
StrongStrong · Growing, Hiring · 18% CAGR over 1y
Location
BROWN & BURK UK LIMITED
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsManufactures, markets and distributes generic pharmaceutical medicines. Supplies EU GMP‑compliant products including antibiotics and other prescription drugs, and manages pharmaceutical supply chains…
Serves B2B healthcare and pharmaceutical buyers, including distributors and supply-chain partners sourcing generic medicinal products across the UK and Europe.
Financial Health
HealthyHealthy · -51% CAGR over 5y
Location
CHARLWOOD PHARMA LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsManufactures and distributes generic prescription medicines through retail pharmacy, wholesale and hospital channels. Develops and markets pharmaceutical products across therapeutic areas including…
Sells to UK healthcare channels, primarily retail pharmacies, pharmaceutical wholesalers and hospitals, supplying prescription medicines across therapeutic areas including cardiovascular, CNS,…
Financial Health
HealthyHealthy · 0% CAGR over 2y
Location
BRISTOL LABORATORIES LIMITED
Trajectory
2y · 2023–NowFinancial sub-scores
Computed from 2 filingsDevelops, manufactures, and distributes generic pharmaceutical medicines for the healthcare sector. Produces and supplies prescription and consumer healthcare products including treatments for…
Sells B2B to healthcare-sector organisations, including medicine wholesalers, pharmacies, hospitals and distributors, primarily in the UK with wider European and international customer markets…
Financial Health
HealthyHealthy · Hiring · 11% CAGR over 1y
Location
NICHE GENERICS LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops, manufactures, packages and supplies generic pharmaceutical medicines. Operates facilities for solid‑dose drug manufacturing, packaging and testing, and distributes finished products through…
Sells to pharmaceutical wholesalers in the UK and selected distribution partners across Europe and other territories, serving B2B buyers in the generic medicines supply chain.
Financial Health
WeakWeak · -2% CAGR over 4y
Location
H & K HEALTHCARE LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops, manufactures and supplies pharmaceutical products including generic medicines, cardiovascular and neurological drugs, sterile injectables, paediatric formulations, and herbal nutraceuticals…
Serves healthcare professionals, hospitals, clinics and pharmaceutical buyers worldwide, including purchasers for generic, specialist, injectable, paediatric, herbal and nutraceutical healthcare…
Financial Health
HealthyHealthy · Hiring · 22% CAGR over 2y
Location
ZYDUS PHARMACEUTICALS UK LTD
Trajectory
2y · 2023–NowDevelops, manufactures, and markets pharmaceutical medicines and healthcare products. Conducts research and development, supplies prescription drugs, and provides medical information and adverse…
Serves healthcare-sector buyers in the UK pharmaceutical market, including organisations involved in prescribing, dispensing, distributing or procuring medicines, with product and medical information…
Financial Health
Insufficient historyInsufficient history
Location
IPCA LABORATORIES UK LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops, manufactures, and supplies pharmaceutical products including active pharmaceutical ingredients (APIs) and generic formulations. Conducts research and development and provides packaging and…
Serves B2B pharmaceutical buyers, distributors and healthcare-sector organisations seeking APIs, formulations and generics, with customers across more than 120 countries.
Financial Health
StrongStrong · Hiring · 360% CAGR over 2y
Location
GENETECH PHARMACEUTICALS LIMITED
Trajectory
4y · 2021–NowFinancial sub-scores
Computed from 4 filingsSupplies and distributes pharmaceutical and healthcare products. Provides NHS and pharmacy supply, international pharmaceutical exports, temperature‑controlled storage and logistics, manufacturer…
Serves NHS organisations, pharmacies, overseas healthcare professionals, pharmaceutical manufacturers and clinical trial sponsors needing pharmaceutical and healthcare product supply, distribution or…
Financial Health
StrongStrong · Hiring · 12% CAGR over 4y
Location
Mirage Distribution Limited
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsWholesale supplier of pharmaceutical and healthcare products. Procures, parallel imports, licences, relabels and distributes branded and generic medicines, medical devices, diagnostics and…
Serves B2B customers in the UK pharmaceutical and healthcare supply chain, including large pharmacy chains, full- and short-line wholesalers, manufacturers and healthcare companies, with a retail…
Financial Health
StableStable · Hiring · 7% CAGR over 4y
Location
Wallace Pharmaceuticals Ltd
Trajectory
2y · 2024–NowFinancial sub-scores
Computed from 2 filingsManufactures and develops pharmaceutical and biotechnology products. Produces prescription medicines and over‑the‑counter treatments across therapeutic areas including antibiotics, cardiovascular,…
Serves healthcare providers, healthcare professionals and patients internationally across prescription and over-the-counter therapeutic areas.
Financial Health
StrongStrong · Growing, Hiring · 11% CAGR over 1y
Location
HNS PHARMA LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsSupplies and distributes pharmaceutical products, including licensed, unlicensed and controlled medicines. Sources drugs globally for healthcare providers, supports clinical trials with comparator…
Serves government and private pharmaceutical buyers, clinical trial teams, aid and development organisations, and UK NHS and healthcare providers needing licensed, unlicensed, controlled or…
Financial Health
WeakWeak · Hiring · 3% CAGR over 4y
Location
Cadila Pharmaceuticals (UK) Limited
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops and manufactures pharmaceutical products and active pharmaceutical ingredients (APIs). Conducts drug discovery and research, and provides formulation development, contract manufacturing and…
Serves pharmaceutical companies, healthcare systems, clinicians and patients, with B2B partners needing APIs, formulations, CDMO/CMO or contract research, and therapy markets including…
Financial Health
DistressedDistressed · -44% CAGR over 2y
Location
PHARMATHEN U.K. LTD
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops and manufactures pharmaceutical products, focusing on complex and long‑acting generic medicines. Conducts research and development, creates drug delivery technologies, and provides finished…
Serves branded pharmaceutical companies, licensors, distributors and affiliates worldwide, as well as commercial partners seeking generic product portfolios and regulatory or technical support.
Financial Health
HealthyHealthy · 7% CAGR over 1y
Location
VERTICAL PHARMA RESOURCES LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsManufactures and supplies unlicensed medicines (“specials”), including bespoke and batch‑compounded formulations. Imports medicines licensed in other jurisdictions, sources low‑volume licensed…
Serves healthcare professionals, pharmaceutical manufacturers, life science and biotech firms, academic institutions, CROs, pharmaceutical wholesalers and patients, mainly in the UK with global…
Financial Health
StableStable · -89% CAGR over 2y
Location
Wallace Manufacturing Chemists Limited
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops, manufactures and supplies licensed medicines, over‑the‑counter healthcare products and nutritional supplements. Produces formulations including capsules, creams, drops, gels, ointments,…
Serves pharmaceutical wholesalers, stockists and exclusive distribution partners in the UK and internationally, reaching healthcare professionals and consumer OTC healthcare markets.
Financial Health
WeakWeak · -5% CAGR over 2y
Location
Macleods Pharma UK Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsSupplies and markets pharmaceutical medicines in the UK as part of an international drug manufacturer. Works with distributors and licensing partners to register, manufacture and supply prescription…
Serves UK patients and healthcare stakeholders, and partners with pharmaceutical distributors in selected European countries through out-licensing arrangements.
Financial Health
StableStable · 0% CAGR over 4y
Location
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsManufactures bespoke “specials” medicines and cannabis‑based products for medicinal use (CBPMs), formulated for patients or animals with specific clinical needs. Also provides manufacturing,…
Serves UK healthcare and veterinary customers, including clinicians, pharmacies and organisations managing patients or animals with special clinical needs for bespoke unlicensed medicines and CBPMs.
Financial Health
StrongStrong · Growing, Hiring · 43% CAGR over 4y
Location
ASPIRE PHARMA LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops, acquires and supplies generic and specialty pharmaceutical medicines. Manages a portfolio of prescription products across therapeutic areas including cardiology, dermatology, oncology and…
Serves patients, healthcare professionals and national health systems in the UK and internationally, across specialist therapeutic areas including cardiology, dermatology, oncology, ophthalmology,…
Financial Health
HealthyHealthy · Hiring · 15% CAGR over 4y
Location
Orchard Pharm Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops, manufactures and markets pharmaceutical products, with integrated capabilities in drug research, formulation development and production. Operates across multiple therapeutic areas and…
Financial Health
StrongStrong · Growing, Hiring · 9% CAGR over 4y
Location
ASCOT LABORATORIES LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsManufactures and supplies customised pharmaceutical specials for human and veterinary use. Provides formulation services, sources hard‑to‑obtain medicines globally, and distributes licensed…
Serves UK healthcare professionals and organisations, alongside veterinary practices and veterinary experts, needing patient-specific human and animal medicines.
Financial Health
StrongStrong · Growing, Hiring · 6% CAGR over 2y
Location
UNI HEALTH DISTRIBUTION LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsImports and wholesales prescription medicines, medical devices and food supplements. Holds parallel import licences to source branded medicines from Europe, repack them for the UK market, and supply…
Serves UK pharmaceutical wholesalers, pharmacy chains and NHS customers needing prescription medicines, medical devices and food supplements sourced from Europe.
Financial Health
HealthyHealthy · Hiring · 4% CAGR over 4y
Location
Smartway PW Holdings Limited
Trajectory
2y · 2020–NowFinancial sub-scores
Computed from 2 filingsSupplies and distributes branded and generic pharmaceuticals globally. Sources comparator drugs, unlicensed and shortage medicines, and manages early access and named‑patient programmes. Provides…
Serves healthcare professionals, hospitals, pharmacies, sexual health clinics, pharma and biotech companies, CROs/CDMOs, wholesalers and distributors, NGOs, charities, multilateral aid organisations…
Financial Health
StableStable · Profitable, Hiring · 25% CAGR over 1y
Location
M BIOTECH LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops and produces pharmaceutical and biotechnology products including antibiotics, antivirals, oncology and cardiovascular medicines. Supplies diagnostic systems, food supplements, medical…
Serves pharmaceutical and healthcare-sector buyers worldwide, including drug distributors, manufacturers, marketing-authorisation holders, clinics and doctors, with pharmacovigilance channels also…
Financial Health
StableStable · Hiring · 41% CAGR over 2y
Location
NECESSITY SUPPLIES LIMITED
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsImports, exports and wholesales pharmaceutical products, supplying generic and branded medicines and healthcare items such as tablets, syringes, creams, inhalers and test strips to pharmacies,…
Serves pharmacies, pharmaceutical wholesalers and distributors, hospitals and care homes in the UK, Europe and globally, targeting buyers in healthcare and care-sector medicine supply chains.
Financial Health
StableStable · Hiring · 7% CAGR over 4y
Location
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsResearches, develops and supplies prescription and over‑the‑counter medicines and speciality pharmaceutical products. Product range includes dermatology treatments, anti‑inflammatory and pain relief…
Sells to UK patients and consumers, healthcare professionals, and pharmaceutical customers seeking medicines, speciality pharmaceuticals and consumer healthcare products across dermatology, pain and…
Financial Health
StableStable · Hiring · 4% CAGR over 4y
Location
Wasdell Holdings Limited
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsProvides contract manufacturing, packaging, storage and distribution services for pharmaceutical and nutraceutical products. Supports healthcare companies with production, supply chain management and…
Serves pharmaceutical and nutraceutical companies needing outsourced support for healthcare products, including businesses supplying medicines and supplements to patients and consumers across global…
Financial Health
StableStable · -8% CAGR over 3y
Location
Mobius Healthcare Limited
Trajectory
4y · 2021–NowFinancial sub-scores
Computed from 4 filingsProvides contract microbiological and sterility testing for pharmaceuticals through an MHRA‑approved laboratory. Also offers pharmaceutical product development support, quality control and batch…
Sells B2B to pharmaceutical, nutraceutical and medical supplies companies, including product licence holders, needing microbiological testing, batch certification, product development, manufacturing,…
Financial Health
StrongStrong · Growing · 0% CAGR over 3y
Location
BRUNSWICK TRADING LIMITED
Trajectory
3y · 2022–NowFinancial sub-scores
Computed from 3 filingsProvides wholesale procurement and distribution of pharmaceutical and healthcare products, including UK generic and branded medicines, medical devices and dressings. Also conducts parallel import and…
Serves licensed pharmaceutical wholesalers, distributors and healthcare product businesses sourcing generics, branded medicines, medical devices and dressings across Europe, the Middle East and…
Financial Health
DistressedDistressed · -11% CAGR over 2y
Location
MANX HEALTHCARE LIMITED
Trajectory
2y · 2023–NowFinancial sub-scores
Computed from 2 filingsDevelops, manufactures and distributes generic and over‑the‑counter pharmaceutical products. Offers a portfolio including medicines for pain relief, travel health, dental care, infections, gut health…
Serves pharmaceutical buyers and healthcare supply-chain customers in the UK and beyond, focused on generic and over-the-counter medicines across therapeutic areas such as pain relief, dental,…
Financial Health
WeakWeak · 0% CAGR over 2y
Location
WORLD MEDICINE LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsManufactures pharmaceutical products, focusing on accessible medicines produced to international quality standards. Activities include development and production of drug formulations using controlled…
Financial Health
StableStable · -68% CAGR over 4y
Location
Smartway Pharmaceuticals Limited
Trajectory
4y · 2020–NowFinancial sub-scores
Computed from 4 filingsSupplies and distributes branded and generic pharmaceutical medicines to healthcare providers, pharmacies, wholesalers and aid organisations. Sources and exports medicines internationally, including…
Serves healthcare professionals, hospitals, pharmacies, sexual health clinics, pharma and biotech firms, CROs/CDMOs, wholesalers, distributors, NGOs, charities, multilateral aid organisations and…
Financial Health
StableStable · Profitable, Hiring · 11% CAGR over 4y
Location
Firstline Pharma Ltd
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsImports, exports and wholesales pharmaceutical and healthcare products, including branded, generic and over‑the‑counter medicines. Sources and supplies unlicensed medicines and clinical trial…
Serves pharmaceutical distributors, pharmacies, private hospitals and clinics, government health departments, NGOs and pharmaceutical manufacturers in Europe, Asia, the Middle East and Africa.
Financial Health
WeakWeak · Hiring · 6% CAGR over 4y
Location
APOLLO PHARMA LTD
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsProvides contract development and manufacturing services to pharmaceutical and healthcare companies, acting as a CMDO partner for the development and production of pharmaceutical and healthcare…
Serves pharmaceutical and healthcare businesses, likely companies seeking outsourced development or manufacturing support from a CMDO partner.
Financial Health
StableStable · Hiring · 6% CAGR over 4y
Location
Alissa Healthcare Research Limited
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsDevelops, licenses, markets and distributes generic and speciality medicines. Supplies pharmaceutical products to healthcare providers and pharmacies and collaborates with partners to bring licensed…
Sells to UK healthcare buyers, particularly the NHS and pharmacies, and serves pharmaceutical customers and collaboration partners in the UK, EU and worldwide. Targets B2B and public sector medicine…
Financial Health
HealthyHealthy · -3% CAGR over 4y
Location
Harvey Pharma Ltd
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsPharmaceutical wholesaler that sources, procures, stores and distributes branded and generic medicines, medical devices and food supplements. Works with manufacturers and distributors to supply and…
Serves B2B healthcare and pharmaceutical buyers, including manufacturers, distributors and healthcare professionals sourcing branded and generic medicines, food supplements and medical devices for…
Financial Health
StableStable · Hiring · 6% CAGR over 3y
Location
FLAMINGO PHARMA (UK) LTD
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsWholesales prescription and over‑the‑counter pharmaceutical products. Acquires, develops and markets generic medicines, supplying tablets, capsules and other treatments through licensing,…
Serves B2B customers in the UK pharmaceuticals market, including healthcare providers and partners seeking generic medicines, own-label supply arrangements and product availability information.
Financial Health
HealthyHealthy · -88% CAGR over 2y
Location
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsMarkets and supplies generic pharmaceutical medicines to wholesale distributors, pharmacies, and healthcare providers. Licenses and markets medicines from third parties and develops generic drugs…
Serves UK pharmaceutical wholesalers, retail pharmacy channels and secondary care healthcare providers, with additional relationships with third-party product licensing partners.
Financial Health
WeakWeak · Hiring · 6% CAGR over 2y
Location
AB BIOTECHNOLOGY LIMITED
Trajectory
4y · 2023–NowFinancial sub-scores
Computed from 4 filingsDevelops and manufactures biopharmaceutical products for research and clinical use. Provides services including peptide synthesis, protein purification, assay development, polyclonal antibody…
Serves biotechnology and pharmaceutical organisations developing biological medicinal or investigational medicinal products, including R&D, quality and manufacturing teams needing GMP-grade…
Financial Health
WeakWeak · -79% CAGR over 3y
Location
C.S.T. PHARMA GROUP HOLDINGS LIMITED
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsOperates a group of companies engaged in wholesale distribution of pharmaceuticals, medical devices, medicines, and health and beauty products, including parallel import and repackaging, supplying…
Serves B2B customers across pharmaceutical and healthcare sectors, including the NHS, private healthcare providers, independent clinics, pharmacies, medical and beauty clinics, and aesthetics…
Financial Health
DistressedDistressed · -32% CAGR over 3y
Location
Clarity Pharma
Trajectory
3y · 2022–NowFinancial sub-scores
Computed from 3 filingsProvides pharmaceutical distribution and market access services, including primary healthcare sales to dispensing doctors and retail pharmacies, third‑party logistics, regulatory support, and…
Serves pharmaceutical and healthcare companies seeking UK market access, plus dispensing doctors and commercial retail pharmacies buying prescription and healthcare products.
Financial Health
StrongStrong · Hiring · 64% CAGR over 2y
Location
Unlock all 5,755 leads
Showing 50 of 5,755 — +5,705 more with verified decision-maker contacts, live data, and CRM sync.
How UK pharmaceuticals companies work and how to sell to them
What they do
Pharmaceutical companies earn revenue through a mix of medicine sales, licence ownership, manufacturing and assembly work, import activity, wholesale distribution and research-adjacent services. Some monetise marketing authorisations and intellectual property through royalties, milestones or territory agreements; others operate on batch-based pricing, transfer-price margins, recurring supply contracts or service fees for regulated work. The product shape is rarely just a physical good. It usually combines medicines, quality systems, release processes, documentation, storage controls and post-market safety obligations. Gross margin depends on where the firm sits in the chain: licence holders and specialist manufacturers face different economics from distributors, importers or clinical-supply operators.
Who they sell to
Most pharmaceutical firms sell to institutional buyers rather than casual end users. Typical customers include public-sector healthcare bodies, private clinical providers, wholesalers, export distributors, research organisations and other medicines companies needing manufacturing, licensing or distribution capacity. Buying groups usually involve regulatory affairs, quality, procurement, medical affairs, supply chain and finance, with senior sign-off where patient safety, liability or reimbursement is involved. Sales cycles tend to be lengthy because customers need qualification, audit evidence, licence checks and service continuity. Routes to market vary between direct commercial teams, tendering, distributor agreements and partner-led arrangements, with smaller projects often becoming recurring supply or support relationships after qualification.
What they buy
Most pharmaceutical firms tend to spend on systems and services that reduce compliance burden and keep supply moving. Common software categories include quality management, regulatory information management, pharmacovigilance, document control, electronic batch records, laboratory systems, enterprise resource planning, warehouse management, cold-chain monitoring, demand planning, security and audit tooling. Service spend often sits around regulatory consultancy, validation, legal advice, accounting, market-access support, medical writing, recruitment and specialist training. Infrastructure needs can include controlled storage, temperature logging, cleanroom support, laboratory capacity and outsourced manufacturing or distribution. Sellers should expect buyers to ask for evidence, implementation controls, data-integrity processes and references from similarly regulated environments.
Why and how to sell to them
Pharmaceutical buyers tend to evaluate vendors when regulatory workload rises, a licence scope changes, a product moves towards commercial supply, facilities are being qualified, or distribution becomes harder to manage. Inspection findings, supplier failures, batch-release delays, pharmacovigilance volume and cold-chain risk can also create buying intent. Outbound messaging works better when it speaks to a specific operational consequence: fewer audit findings, cleaner documentation, faster supplier qualification, better traceability, lower manual effort or improved readiness for inspection. Generic productivity claims are less persuasive in this market. Procurement teams usually need a clear compliance case, implementation plan and ownership model before a commercial sponsor can justify switching from an incumbent process.
How this list is built
Data sources
This list is built from UK Companies House filings, XBRL accounts data, and semantic analysis of each company's public website. Revenue and headcount figures come from the most recent filed accounts; where the company has not filed, values are estimated using a model trained on filed history and peer benchmarks and are labelled as estimates.
Classification
Rather than relying solely on SIC codes, Firmbase classifies each company semantically: the company's website is crawled, an AI model reads what the company actually sells, and the company is placed into the relevant industry and subsectors. SIC codes are used as one signal but not the only one. This means a company that registered under a generic SIC code but pivoted into (for example) fintech is correctly identified as fintech, not as its original SIC category.
Freshness
The underlying company data is refreshed from Companies House continuously; filings appear in the list within days of submission. The curated list ordering is regenerated when the underlying data moves meaningfully (company count changes by more than 5%, a new company enters the top-ranked segment, or the filed-revenue numbers for the top firms change). You can see the last-updated timestamp near the top of the page.
Related directories
Frequently asked questions
How many pharmaceuticals companies are there in the UK?↓
What counts as a pharmaceuticals company in this list?↓
Which are the largest pharmaceuticals companies in the UK?↓
What do pharmaceuticals companies in the UK actually do?↓
How does UK pharmaceuticals compare internationally?↓
How is this list built and how fresh is the data?↓
How big are the typical pharmaceuticals companies in the UK?↓
Are these mostly new or established pharmaceuticals companies?↓
What SIC codes does this use?↓
What buying signals should I look for?↓
Push these 5,755 companies into your pipeline.
Find the right decision-makers, see verified company data, and export your list in seconds.